Skip to content
MarketScale
‹ Back to IndustriesSciences

Demands of Smartphone Camera Quality Drive Manufacturing Process Improvements

The article discusses the improvements in smartphone camera quality and how these demands are driving advancements in manufacturing processes. ZYGO, an optical technology company, is using its Compass microlens process metrology system to ensure that these manufacturing processes meet industry standards. This system helps in controlling the production of high-performance imaging camera modules in smartphones.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

Promoted content from SMART Technologies on MarketScale.

By Sciences · Promoted Content
Share
Demands of Smartphone Camera Quality Drive Manufacturing Process Improvements

Key takeaways

01

One billion smartphones are shipped each year, resulting in countless pictures taken.

02

Cell phone image quality has significantly improved in recent years.

03

ZYGO uses its Compass microlens process to maintain precision in smartphone camera manufacturing.

With one billion smartphones shipped every year, there are an infinite number of pictures taken by these handheld devices as well. And in the past few years, cell phone image quality has undergone vast improvements. While the average consumer may not have noticed these enhancements, ZYGO has.

Not just because we’re an optical technology company who happen to make clever, innovative products. Rather, it’s because we get to see how our efforts impact the daily lives of millions of people as they capture life’s moments via their smart, but seemingly simple, phones.

Amazingly, these seemingly simple devices are packed with exceedingly smart technologies – one of which is the versatile camera lens module. Each smartphone’s camera lens module consists of multiple discrete lens elements that work in unison to provide high-performance imaging.

We are introducing our solution to the industry, and ultimately consumers – the Compass™ microlens process metrology system. The Compass system in an on-line production control tool that enables the rapid measurement and control of critical micro lenses and lens molds, ensuring that design parameters are being met while keeping the manufacturing process in control.

The Compass system employs proprietary and innovative ZYGO optical technology to uphold the precision, automation, and production throughput standards that can meet both current and future industry needs.

To ensure superior selfies, both now and beyond, check out the revolutionary ZYGO Compass™ micro lens process metrology system.

Read more at zygo.com

SMART Technologies

Part of this channel

SMART Technologies

Interactive learning technology trusted by educators worldwide

Visit the channel

About the author

S
Sciences

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Sciences expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics taps photonics veteran Neil Anderson as CRO to scale flat optics into AI datacenters and AR

Myrias Optics has hired Neil Anderson, Ph.D. as the Chief Revenue Officer to spearhead the commercialization of its nanoimprint flat optics platform. The platform is intended for use in AI datacenters, augmented reality (AR), and life sciences applications. Anderson's experience in photonics is expected to aid Myrias Optics in expanding its market presence in these sectors.

  • 01Myrias Optics appointed Neil Anderson, Ph.D. as CRO to lead the commercialization of its technology.
  • 02The company focuses on nanoimprint flat optics for AI datacenters, AR, and life sciences.
  • 03Neil Anderson brings extensive photonics expertise to support Myrias Optics' growth.

Jul 31, 2026

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

Biopharma's $300 Billion Problem Is Driving the Biggest M&A Cycle in a Decade

The pharmaceutical industry is facing a significant challenge as over $300 billion in branded pharmaceutical revenue is set to lose patent protection by 2030. This revenue gap is driving the largest merger and acquisition cycle seen in a decade, with companies seeking external growth through acquisitions. This shift is impacting the entire life sciences supply chain, prompting strategic changes across the industry.

  • 01Over $300 billion in pharmaceutical revenue is at risk due to patent expirations by 2030.
  • 02Big Pharma is engaging in an aggressive cycle of mergers and acquisitions.
  • 03The acquisitions are reshaping the life sciences supply chain.

Jun 29, 2026

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences launches Phase I study of what it calls the first AI-formulated drug in the clinic

Quotient Sciences has initiated a Phase I clinical study at its UK facility for an oral solid dose formulation designed using artificial intelligence — what the company believes is the first AI-formulated drug to reach human clinical evaluation. The study, cleared by the UK's Medicines and Healthcare products Regulatory Agency, will assess safety and pharmacokinetics in healthy volunteers. The program, which used Intrepid Labs' machine learning algorithm, signals a broader shift in how contract drug development organizations are integrating AI across formulation and clinical workflows.

  • 01Quotient Sciences initiated a Phase I study of an AI-designed oral solid dose formulation at its UK facility following MHRA approval — the first such case the company believes has been reported.
  • 02The formulation was developed using Intrepid Labs' advanced machine learning algorithm in combination with Quotient Sciences' Translational Pharmaceutics platform.
  • 03The milestone is part of a broader CRDMO strategy to embed AI-enabled approaches across formulation development and clinical workflows, with implications for the wider contract pharma sector.

Jun 17, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512